The role of diffuse optical spectroscopy in the clinical management of breast cancer

Diffuse optical spectroscopy (DOS) of breast tissue provides quantitative, functional information based on optical absorption and scattering properties that cannot be obtained with other radiographic methods. DOS-measured absorption spectra are used to determine the tissue concentrations of deoxyhem...

Full description

Saved in:
Bibliographic Details
Published in:Disease markers 2004, Vol.19 (2-3), p.95-105
Main Authors: Shah, Natasha, Cerussi, Albert E, Jakubowski, Dorota, Hsiang, David, Butler, John, Tromberg, Bruce J
Format: Article
Language:English
Subjects:
Biophysical Phenomena
Biophysics
Breast Neoplasms - diagnosis
Breast Neoplasms - therapy
Female
Hemoglobins - chemistry
Humans
Hypoxia
Magnetic Resonance Imaging - methods
Neovascularization, Pathologic
Other
Oxygen - chemistry
Photons
Spectrophotometry
Spectrum Analysis
Water
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Diffuse optical spectroscopy (DOS) of breast tissue provides quantitative, functional information based on optical absorption and scattering properties that cannot be obtained with other radiographic methods. DOS-measured absorption spectra are used to determine the tissue concentrations of deoxyhemoglobin (Hb-R), oxyhemoglobin (Hb-O2), lipid, and water (H2O), as well as to provide an index of tissue hemoglobin oxygen saturation (StO2). Tissue-scattering spectra provide insight into epithelial, collagen, and lipid contributions to breast density. Clinical studies of women with malignant tumors show that DOS is sensitive to processes such as increased tissue vascularization, hypoxia, and edema. In studies of healthy women, DOS detects variations in breast physiology associated with menopausal status, menstrual cycle changes, and hormone replacement. Current research involves using DOS to monitor tumor response to therapy and the co-registration of DOS with magnetic resonance imaging. By correlating DOS-derived parameters with lesion pathology and specific molecular markers, we anticipate that composite "tissue optical indices" can be developed that non-invasively characterize both tumor and normal breast-tissue function.
ISSN:0278-0240
1875-8630
DOI:10.1155/2004/460797